CEBU, Philippines -- Nuevocor, a Singapore-based preclinical-stage biotech startup, has raised an additional $11.6 million in funding from existing investors, according to regulatory filings.
DealStreetAsia
Singapore gene therapy startup Nuevocor snags more funding
Biotech company pulls in another $11.6m from existing investors
Singapore-based preclinical-stage biotech startup Nuevocor develops gene therapy for the treatment of cardiac diseases. (Photo by AP)
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on DealStreetAsia
